ADMA - ADMA Biologics EPS beats by $0.01 beats on revenue November, 05 2020 04:37 PM ADMA Biologics Inc ADMA Biologics (ADMA): Q3 GAAP EPS of -$0.19 beats by $0.01.Revenue of $10.28M (+42.4% Y/Y) beats by $0.46M.Shares +1.9%.Press Release For further details see: ADMA Biologics EPS beats by $0.01, beats on revenue